Related Experiment Video
Updated: Sep 27, 2026

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Palliative care in tuberculosis: Need, challenges and future directions for India
Rajam K Iyer1, Rajani S Bhat2, Sreedevi Warrier3
1Lakshmi Pain and Palliative Care Trust, Chennai, India.
Abstract:
Tuberculosis (TB) continues to be a major public health challenge in India, contributing significantly to mortality, morbidity, and long-term disability. Although TB is considered a curable disease, people with TB frequently experience substantial physical, psychological, social, and spiritual suffering throughout the disease trajectory. Drug-resistant tuberculosis (DR-TB), recurrent TB, HIV-associated TB, severe extrapulmonary disease, and post-tuberculosis lung disease (PTLD) are associated with particularly high symptom burden and impaired quality of life. Traditionally, palliative care has been associated with advanced cancer and end-of-life care; however, emerging evidence suggests that palliative care should be integrated early into TB care to relieve suffering, improve treatment adherence, and support people affected by TB and caregivers. Palliative care for people with TB has several distinctive considerations, including the need to integrate symptom relief and psychosocial support with ongoing disease-directed treatment and, where relevant, communicable-disease-control measures. India's National TB Elimination Programme (NTEP) already incorporates several patient-support mechanisms, including nutritional support, counselling, peer support, and community-based interventions. However, comprehensive palliative care services remain underdeveloped within TB care pathways. This review discusses the need for palliative care in tuberculosis, examines distinctive considerations in TB palliative care, assesses implementation challenges in India, and proposes feasible models for integration within the Indian healthcare system. The review advocates for a person-centred, multidisciplinary, and decentralized approach aligned with the WHO End TB Strategy and emerging national guidance documents.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
